Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1373 ARTÍCULOS , VIENDO DEL 1321 AL 1335

Early Alzheimer's and Parkinson's disease pathology in urban children: Friend versus Foe responses--it is time to face the evidence

Calderón-Garcidueñas L, Franco-Lira M, Mora-Tiscareño A, Medina-Cortina H, Torres-Jardón R, Kavanaugh M.

Biomed Res Int. 2013;2013:161687. doi: 10.1155/2013/161687. Epub 2013 Feb 7.

Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study

Pedersen KF, Larsen JP, Tysnes OB, Alves G.

JAMA Neurol. 2013 May;70(5):580-6. doi: 10.1001/jamaneurol.2013.2110.

Can mild cognitive impairment in Parkinson disease predict the development of dementia?

Copeland BJ, Schiess MC.

JAMA Neurol. 2013 May;70(5):553-5. doi: 10.1001/jamaneurol.2013.260.

Ghrelin as a neuroprotective and palliative agent in Alzheimer's and Parkinson's disease

Dos Santos VV, Rodrigues AL, De Lima TC, de Barioglio SR, Raisman-Vozari R, Prediger RD.

Curr Pharm Des. 2013;19(38):6773-90. doi: 10.2174/13816128113199990411.

A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies

Nalls MA, Duran R, Lopez G, Kurzawa-Akanbi M, McKeith IG, Chinnery PF, Morris CM, Theuns J, Crosiers D, Cras P, Engelborghs S, De Deyn PP, Van Broeckhoven C, Mann DM, Snowden J, Pickering-Brown S, Halliwell N, Davidson Y, Gibbons L, Harris J, Sheerin UM, Bras J, Hardy J, Clark L, Marder K, Honig LS, Berg D, Maetzler W, Brockmann K, Gasser T, Novellino F, Quattrone A, Annesi G, De Marco EV, Rogaeva E, Masellis M, Black SE, Bilbao JM, Foroud T, Ghetti B, Nichols WC, Pankratz N, Halliday G, Lesage S, Klebe S, Durr A, Duyckaerts C, Brice A, Giasson BI, Trojanowski JQ, Hurtig HI, Tayebi N, Landazabal C, Knight MA, Keller M, Singleton AB, Wolfsberg TG, Sidransky E.

JAMA Neurol. 2013 Jun;70(6):727-35. doi: 10.1001/jamaneurol.2013.1925.

α-Synuclein in cerebrospinal fluid of Alzheimer's disease and mild cognitive impairment

Korff A, Liu C, Ginghina C, Shi M, Zhang J; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2013;36(4):679-88. doi: 10.3233/JAD-130458.

[Fall risk and fracture. Falls in patients with dementia]

Komatsu T.

Clin Calcium. 2013 May;23(5):731-8.

[Smoking and neurological disorders]

Fujii H, Hosomi N, Matsumoto M.

Nihon Rinsho. 2013 Mar;71(3):423-9.

Progress in stem cell therapy for major human neurological disorders

Martínez-Morales PL, Revilla A, Ocaña I, González C, Sainz P, McGuire D, Liste I.

Stem Cell Rev Rep. 2013 Oct;9(5):685-99. doi: 10.1007/s12015-013-9443-6.

Ascending monoaminergic systems alterations in Alzheimer's disease. translating basic science into clinical care

Trillo L, Das D, Hsieh W, Medina B, Moghadam S, Lin B, Dang V, Sanchez MM, De Miguel Z, Ashford JW, Salehi A.

Neurosci Biobehav Rev. 2013 Sep;37(8):1363-79. doi: 10.1016/j.neubiorev.2013.05.008. Epub 2013 May 24.

Metal dyshomeostasis and inflammation in Alzheimer's and Parkinson's diseases: possible impact of environmental exposures

Myhre O, Utkilen H, Duale N, Brunborg G, Hofer T.

Oxid Med Cell Longev. 2013;2013:726954. doi: 10.1155/2013/726954. Epub 2013 Apr 17.

Evaluation of Parkinson disease and Alzheimer disease with the use of neuromelanin MR imaging and (123)I-metaiodobenzylguanidine scintigraphy

Miyoshi F, Ogawa T, Kitao SI, Kitayama M, Shinohara Y, Takasugi M, Fujii S, Kaminou T.

AJNR Am J Neuroradiol. 2013 Nov-Dec;34(11):2113-8. doi: 10.3174/ajnr.A3567. Epub 2013 Jun 6.

Comparison of quantitative EEG between patients with Alzheimer's disease and those with Parkinson's disease dementia

Fonseca LC, Tedrus GM, Carvas PN, Machado EC.

Clin Neurophysiol. 2013 Oct;124(10):1970-4. doi: 10.1016/j.clinph.2013.05.001. Epub 2013 Jun 5.

Caring for parents with neurodegenerative disease: a qualitative description

Habermann B, Hines D, Davis L.

Clin Nurse Spec. 2013 Jul-Aug;27(4):182-7. doi: 10.1097/NUR.0b013e318295576b.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias